BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Senzolo M, Burra P, Cholongitas E, Burroughs A. New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol 2006; 12(48): 7725-7736 [PMID: 17203512 DOI: 10.3748/wjg.v12.i48.7725] [Cited by in CrossRef: 110] [Cited by in F6Publishing: 83] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Bouchard J, Madore F. Role of citrate and other methods of anticoagulation in patients with severe liver failure requiring continuous renal replacement therapy. NDT Plus 2009;2:11-9. [PMID: 25949276 DOI: 10.1093/ndtplus/sfn184] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
2 Bonnet A, Gilquin N, Steer N, Gazon M, Quattrone D, Pradat P, Maynard M, Mabrut J, Aubrun F. The use of a thromboelastometry-based algorithm reduces the need for blood product transfusion during orthotopic liver transplantation: A randomised controlled study. European Journal of Anaesthesiology 2019;36:825-33. [DOI: 10.1097/eja.0000000000001084] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 7.5] [Reference Citation Analysis]
3 Cruz-Ramón V, Chinchilla-López P, Ramírez-Pérez O, Aguilar-Olivos NE, Alva-López LF, Fajardo-Ordoñez E, Ponciano-Rodríguez G, Northup PG, Intagliata N, Caldwell SH, Qi X, Méndez-Sánchez N. Thrombosis of the Portal Venous System in Cirrhotic vs. Non-Cirrhotic Patients. Ann Hepatol 2018;17:476-81. [PMID: 29735798 DOI: 10.5604/01.3001.0011.7392] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
4 Lesmana CR, Inggriani S, Cahyadinata L, Lesmana LA. Deep vein thrombosis in patients with advanced liver cirrhosis: a rare condition? Hepatol Int. 2010;4:433-438. [PMID: 20305762 DOI: 10.1007/s12072-010-9166-6] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
5 Kotronen A, Yki-järvinen H. Fatty Liver: A Novel Component of the Metabolic Syndrome. ATVB 2008;28:27-38. [DOI: 10.1161/atvbaha.107.147538] [Cited by in Crossref: 541] [Cited by in F6Publishing: 251] [Article Influence: 41.6] [Reference Citation Analysis]
6 Gong X, Gutala R, Jaiswal AK. Quinone Oxidoreductases and Vitamin K Metabolism. Vitamin K. Elsevier; 2008. pp. 85-101. [DOI: 10.1016/s0083-6729(07)00005-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
7 Ng VL. Liver disease, coagulation testing, and hemostasis. Clin Lab Med. 2009;29:265-282. [PMID: 19665678 DOI: 10.1016/j.cll.2009.05.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
8 Gurumurthy G, Gaddam A, Patel V, Patel RS. Coagulopathy and Hospital Outcomes in Patients With Spontaneous Bacterial Peritonitis: A Call for Action to Improve Care of Inpatients. Cureus 2020;12:e8926. [PMID: 32760626 DOI: 10.7759/cureus.8926] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Rodríguez-Castro KI, Porte RJ, Nadal E, Germani G, Burra P, Senzolo M. Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation. 2012;94:1145-1153. [PMID: 23128996 DOI: 10.1097/tp.0b013e31826e8e53] [Cited by in Crossref: 135] [Cited by in F6Publishing: 45] [Article Influence: 16.9] [Reference Citation Analysis]
10 Yang Lu S, Tanaka KA, Abuelkasem E, Planinsic RM, Sakai T. Clinical applicability of rapid thrombelastography and functional fibrinogen thrombelastography to adult liver transplantation: RAPID TEG IN LIVER TRANSPLANTATION. Liver Transpl 2014;20:1097-105. [DOI: 10.1002/lt.23923] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
11 Saha A, Naidu C, Ramesh G, Chatterjee J, Puri P, Nandi B, Nambiar P, Madan R. Liver transplantation in Indian Armed Forces-initial experience. Med J Armed Forces India 2012;68:110-7. [PMID: 24669047 DOI: 10.1016/S0377-1237(12)60018-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
12 Draoua M, Titze N, Gupta A, Fernandez HT, Ramsay M, Saracino G, Mckenna G, Testa G, Klintmalm GB, Kim PTW. Significance of measured intraoperative portal vein flows after thrombendvenectomy in deceased donor liver transplantations with portal vein thrombosis. Liver Transpl 2017;23:1032-9. [DOI: 10.1002/lt.24779] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
13 Al-ruzzeh S, Navia JL. The “Off-Label” Role of Recombinant Factor VIIa in Surgery: Is the Problem Deficient Evidence or Defective Concept? Journal of the American College of Surgeons 2009;209:659-67. [DOI: 10.1016/j.jamcollsurg.2009.07.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
14 Verbeek TA, Stine JG, Saner FH, Bezinover D. Hypercoagulability in End-stage Liver Disease: Review of Epidemiology, Etiology, and Management. Transplant Direct 2018;4:e403. [PMID: 30534594 DOI: 10.1097/TXD.0000000000000843] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 4.3] [Reference Citation Analysis]
15 Saner FH, Bezinover D. Assessment and management of coagulopathy in critically-ill patients with liver failure. Curr Opin Crit Care. 2019;25:179-186. [PMID: 30855324 DOI: 10.1097/mcc.0000000000000591] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
16 Senzolo M, Sartori MT, Lisman T. Should we give thromboprophylaxis to patients with liver cirrhosis and coagulopathy? HPB (Oxford). 2009;11:459-464. [PMID: 19816608 DOI: 10.1111/j.1477-2574.2009.00079.x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 4.1] [Reference Citation Analysis]
17 Zanetto A, Rodriguez-kastro K, Germani G, Ferrarese A, Cillo U, Burra P, Senzolo M. Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis. Transpl Int 2018;31:1318-29. [DOI: 10.1111/tri.13353] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 14.3] [Reference Citation Analysis]
18 Alkim H, Ayaz S, Sasmaz N, Oguz P, Sahin B. Hemostatic Abnormalities in Cirrhosis and Tumor-Related Portal Vein Thrombosis. Clin Appl Thromb Hemost 2012;18:409-15. [DOI: 10.1177/1076029611427900] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
19 Pradhan-Sundd T, Gudapati S, Kaminski TW, Ragni MV. Exploring the Complex Role of Coagulation Factor VIII in Chronic Liver Disease. Cell Mol Gastroenterol Hepatol 2021;12:1061-72. [PMID: 33705963 DOI: 10.1016/j.jcmgh.2021.02.014] [Reference Citation Analysis]
20 Chang JC. TTP-like syndrome: novel concept and molecular pathogenesis of endotheliopathy-associated vascular microthrombotic disease. Thromb J 2018;16:20. [PMID: 30127669 DOI: 10.1186/s12959-018-0174-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
21 Bezinover D, Dirkmann D, Findlay J, Guta C, Hartmann M, Nicolau-raducu R, Mukhtar AM, Moguilevitch M, Pivalizza E, Rosenfeld D, Saner F, Wray C, Wagener G, West J. Perioperative Coagulation Management in Liver Transplant Recipients. Transplantation 2018;102:578-92. [DOI: 10.1097/tp.0000000000002092] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 10.3] [Reference Citation Analysis]
22 Franchini M, Montagnana M, Targher G, Zaffanello M, Lippi G. The use of recombinant factor VIIa in liver diseases. Blood Coagulation & Fibrinolysis 2008;19:341-8. [DOI: 10.1097/mbc.0b013e32830496a7] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
23 Chung H, Cho S, Park C. Effects of Liver Function on Ionized Hypocalcaemia following Rapid Blood Transfusion. J Int Med Res 2012;40:572-82. [DOI: 10.1177/147323001204000219] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
24 Chang JC. Hemostasis based on a novel 'two-path unifying theory' and classification of hemostatic disorders. Blood Coagul Fibrinolysis 2018;29:573-84. [PMID: 30063477 DOI: 10.1097/MBC.0000000000000765] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
25 Paydar S, Mahmoudi Nezhad GS, Karami MY, Abdolrahimzadeh H, Samadi M, Makarem A, Noorafshan A. Stereological Comparison of Imbibed Fibrinogen Gauze versus Simple Gauze in External Packing of Grade IV Liver Injury in Rats. Bull Emerg Trauma 2019;7:41-8. [PMID: 30719465 DOI: 10.29252/beat-070106.] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Aller MA, Arias JL, Cruz A, Arias J. Inflammation: a way to understanding the evolution of portal hypertension. Theor Biol Med Model 2007;4:44. [PMID: 17999758 DOI: 10.1186/1742-4682-4-44] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
27 Kao ML, Lin PY, Heish CE, Chou CT, Lin KH, Ko CJ, Lin CC, Chen YL. Predictors of intra-abdominal coagulopathic hemorrhage after living donor liver transplantation. Int J Surg 2013;11:1073-7. [PMID: 24161418 DOI: 10.1016/j.ijsu.2013.10.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
28 Blonski W, Siropaides T, Reddy KR. Coagulopathy in liver disease. Curr Treat Options Gastroenterol 2007;10:464-73. [PMID: 18221607 DOI: 10.1007/s11938-007-0046-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
29 Patil AG, Bihari C, Shewade HD, Nigam N, Sarin SK. Decreased protein C function predicts mortality in patients with cirrhosis. Int J Lab Hematol. 2018;40:466-472. [PMID: 29704446 DOI: 10.1111/ijlh.12836] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
30 DeAngelis GA, Khot R, Haskal ZJ, Maitland HS, Northup PG, Shah NL, Caldwell SH. Bleeding Risk and Management in Interventional Procedures in Chronic Liver Disease. J Vasc Interv Radiol 2016;27:1665-74. [PMID: 27595469 DOI: 10.1016/j.jvir.2016.05.039] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
31 Mittermayr M, Streif W, Haas T, Fries D, Velik-salchner C, Klingler A, Innerhofer P. Effects of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo. British Journal of Anaesthesia 2008;100:307-14. [DOI: 10.1093/bja/aem363] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 4.0] [Reference Citation Analysis]
32 Gentry P, Burgess H, Wood D. Hemostasis. Clinical Biochemistry of Domestic Animals. Elsevier; 2008. pp. 287-330. [DOI: 10.1016/b978-0-12-370491-7.00010-6] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
33 Vucelic D, Jesic R, Jovicic S, Zivotic M, Grubor N, Trajkovic G, Canic I, Elezovic I, Antovic A. Comparison of standard fibrinogen measurement methods with fibrin clot firmness assessed by thromboelastometry in patients with cirrhosis. Thrombosis Research 2015;135:1124-30. [DOI: 10.1016/j.thromres.2015.04.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
34 Bang SR, Kim YH, Kim GS. The effects of in vitro hemodilution with 6% hydroxyethyl starch (HES) (130/0.4) solution on thrombelastograph analysis in patients undergoing liver transplantation: The effect of hemodilution on blood coagulation. Clinical Transplantation 2011;25:450-6. [DOI: 10.1111/j.1399-0012.2010.01294.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
35 Karakoc D, Hamaloglu E, Ozdemir A, Dogrul A, Ozenc A. The effect of hepatectomy on coagulation: an evaluation by thromboelastography. Eur J Gastroenterol Hepatol. 2010;22:43-48. [PMID: 19773665 DOI: 10.1097/meg.0b013e32832f5bd1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
36 Khafagy HF, Hussein NA, Radwan KG, Refaat AI, Hafez HS, Essawy FM, Kamel HH. Effect of general and epidural anesthesia on hemostasis and fibrinolysis in hepatic patients. Hematology 2013;15:360-7. [DOI: 10.1179/102453310x12647083620886] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Gouvêa G, Toledo R, Diaz R, Auler L, Enne M, Martinho JM. Protamine sulphate for treatment of severe post-reperfusion coagulopathy in pediatric liver transplantation. Pediatr Transplant 2009;13:1053-7. [PMID: 19077136 DOI: 10.1111/j.1399-3046.2008.01108.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
38 Ferro D, Celestini A, Violi F. Hyperfibrinolysis in liver disease. Clin Liver Dis 2009;13:21-31. [PMID: 19150306 DOI: 10.1016/j.cld.2008.09.008] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
39 Lau P, Ong V, Tan WT, Koh PL, Hartman M. Use of Activated Recombinant Factor VII in Severe Bleeding - Evidence for Efficacy and Safety in Trauma, Postpartum Hemorrhage, Cardiac Surgery, and Gastrointestinal Bleeding. Transfus Med Hemother 2012;39:139-50. [PMID: 22670132 DOI: 10.1159/000338034] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
40 Kim SY, Kim JE, Kim YJ, Han KS, Kim HK. Prominent protein Z-induced thrombin inhibition in cirrhosis: a new functional assay for hypercoagulability assessment. J Gastroenterol Hepatol 2015;30:784-93. [PMID: 25303721 DOI: 10.1111/jgh.12800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
41 Roberts LN, Patel RK, Arya R. Haemostasis and thrombosis in liver disease. British Journal of Haematology 2010;148:507-21. [DOI: 10.1111/j.1365-2141.2009.08021.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 56] [Article Influence: 6.5] [Reference Citation Analysis]
42 Aldawood A, Arabi Y, Aljumah A, Alsaadi A, Rishu A, Aldorzi H, Alqahtani S, Alsultan M, Felemban A. The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients. Thromb J. 2011;9:1. [PMID: 21244669 DOI: 10.1186/1477-9560-9-1] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 6.8] [Reference Citation Analysis]
43 Cherian TP, Chiu K, Gunson B, Bramhall SR, Mayer D, Mirza DF, Buckels JA. Pulmonary thromboembolism in liver transplantation: a retrospective review of the first 25 years. Transpl Int. 2010;23:1113-1119. [PMID: 20497402 DOI: 10.1111/j.1432-2277.2010.01105.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
44 Saxena P, Bihari C, Rastogi A, Agarwal S, Anand L, Sarin SK. Sonoclot signature analysis in patients with liver disease and its correlation with conventional coagulation studies. Adv Hematol 2013;2013:237351. [PMID: 24396346 DOI: 10.1155/2013/237351] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
45 Campbell RAS, Thomson EM, Beattie C. Effect of Liver Disease Etiology on ROTEM Profiles in Patients Undergoing Liver Transplantation. Transplant Proc 2019;51:783-9. [PMID: 30979465 DOI: 10.1016/j.transproceed.2018.12.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Chang JC. Thrombogenesis and thrombotic disorders based on 'two-path unifying theory of hemostasis': philosophical, physiological, and phenotypical interpretation. Blood Coagul Fibrinolysis 2018;29:585-95. [PMID: 30234545 DOI: 10.1097/MBC.0000000000000769] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
47 Harrison MF. The Misunderstood Coagulopathy of Liver Disease: A Review for the Acute Setting. West J Emerg Med. 2018;19:863-871. [PMID: 30202500 DOI: 10.5811/westjem.2018.7.37893] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
48 Tischer S, Miller JT. Pharmacologic Strategies to Prevent Blood Loss and Transfusion in Orthotopic Liver Transplantation. Critical Care Nursing Quarterly 2016;39:267-80. [DOI: 10.1097/cnq.0000000000000120] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
49 Senzolo M, Agarwal S, Zappoli P, Vibhakorn S, Mallett S, Burroughs AK. Heparin-like effect contributes to the coagulopathy in patients with acute liver failure undergoing liver transplantation. Liver Int. 2009;29:754-759. [PMID: 19220741 DOI: 10.1111/j.1478-3231.2009.01977.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
50 Jüttner B, Brock J, Weissig A, Becker T, Studzinski A, Osthaus WA, Bornscheuer A, Scheinichen D. Dependence of platelet function on underlying liver disease in orthotopic liver transplantation. Thromb Res 2009;124:433-8. [PMID: 19616824 DOI: 10.1016/j.thromres.2009.06.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
51 Amaral B, Vicente M, Pereira CSM, Araújo T, Ribeiro A, Pereira R, Perdigoto R, Marcelino P. Approach to the liver transplant early postoperative period: an institutional standpoint. Rev Bras Ter Intensiva 2019;31:561-70. [PMID: 31967233 DOI: 10.5935/0103-507X.20190076] [Reference Citation Analysis]
52 Luyendyk JP, Cantor GH, Kirchhofer D, Mackman N, Copple BL, Wang R. Tissue factor-dependent coagulation contributes to alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice. Am J Physiol Gastrointest Liver Physiol 2009;296:G840-9. [PMID: 19179621 DOI: 10.1152/ajpgi.90639.2008] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
53 Senzolo M, Cholongitas E, Thalheimer U, Riddell A, Agarwal S, Mallett S, Ferronato C, Burroughs A. Heparin-like Effect in Liver Disease and Liver Transplantation. Clinics in Liver Disease 2009;13:43-53. [DOI: 10.1016/j.cld.2008.09.004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
54 Ciavarella A, Gnocchi D, Custodero C, Lenato GM, Fiore G, Sabbà C, Mazzocca A. Translational insight into prothrombotic state and hypercoagulation in nonalcoholic fatty liver disease. Thromb Res 2021;198:139-50. [PMID: 33340925 DOI: 10.1016/j.thromres.2020.12.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
55 Ikura Y, Osuga T. Changing common sense: Anti-platelet/coagulation therapy against cirrhosis. World J Hepatol 2015; 7(13): 1730-1734 [PMID: 26167245 DOI: 10.4254/wjh.v7.i13.1730] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
56 De Santis GC, Prata KL, Rodrigues RB, Sankarankutty AK, de Castro e Silva O, Covas DT. Blood group O patients require more blood transfusion in orthotopic liver transplantation. Transfus Apher Sci 2014;50:312-3. [PMID: 24485953 DOI: 10.1016/j.transci.2014.01.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Ponziani FR, De Stefano V, Gasbarrini A. Viral cirrhosis: an overview of haemostatic alterations and clinical consequences. Mediterr J Hematol Infect Dis 2009;1:e2009033. [PMID: 21415961 DOI: 10.4084/MJHID.2009.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
58 Chang JC. Disseminated intravascular coagulation: is it fact or fancy? Blood Coagul Fibrinolysis 2018;29:330-7. [PMID: 29621007 DOI: 10.1097/MBC.0000000000000727] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
59 Chien RN, Kao JH, Peng CY, Chen CH, Liu CJ, Huang YH, Hu TH, Yang HI, Lu SN, Ni YH, Chuang WL, Lee CM, Wu JC, Chen PJ, Liaw YF. Taiwan consensus statement on the management of chronic hepatitis B. J Formos Med Assoc. 2019;118:7-38. [PMID: 30527436 DOI: 10.1016/j.jfma.2018.11.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
60 Andiç N, Karakuş S, Ilhan G, Haberal M. Management of Recurrent Thrombosis in Liver Transplant Recipients: A Case Report. Transplantation Proceedings 2008;40:322-3. [DOI: 10.1016/j.transproceed.2007.11.070] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
61 Patrono D, Romagnoli R, Tandoi F, Maroso F, Bertolotti G, Berchialla P, Strignano P, Brunati A, Lupo F, Salizzoni M. Peri-hepatic gauze packing for the control of haemorrhage during liver transplantation: A retrospective study. Digestive and Liver Disease 2016;48:414-22. [DOI: 10.1016/j.dld.2015.11.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
62 Krisper P, Tiran B, Fliser D, Haditsch B, Stadlbauer V, Otto R, Ernst T, Kretschmer U, Stauber RE, Haller H, Holzer H, Manns MP, Rifai K. Efficacy and Safety of Anticoagulation With Heparin Versus Heparin Plus Epoprostenol in Patients Undergoing Extracorporeal Liver Support With Prometheus. Artificial Organs 2010;34:84-8. [DOI: 10.1111/j.1525-1594.2009.00793.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
63 Peiris P, Pai S, Aniskevich S, Crawford CC, Torp KD, Ladlie BL, Shine TS, Taner CB, Nguyen JH. Intracardiac thrombosis during liver transplant: A 17-year single-institution study: Intracardiac Thrombosis During Liver Transplant. Liver Transpl 2015;21:1280-5. [DOI: 10.1002/lt.24161] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
64 McMurry HS, Jou J, Shatzel J. The hemostatic and thrombotic complications of liver disease. Eur J Haematol 2021. [PMID: 34258797 DOI: 10.1111/ejh.13688] [Reference Citation Analysis]
65 Basili S, Raparelli V, Violi F. The coagulopathy of chronic liver disease: is there a causal relationship with bleeding? Yes. Eur J Intern Med. 2010;21:62-64. [PMID: 20206871 DOI: 10.1016/j.ejim.2010.01.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
66 Luyendyk J, Roth R, Ganey P. Inflammation and Hepatotoxicity. Comprehensive Toxicology. Elsevier; 2010. pp. 295-317. [DOI: 10.1016/b978-0-08-046884-6.01031-9] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
67 De Gasperi A, Corti A, Mazza E, Prosperi M, Amici O, Bettinelli L. Acute Liver Failure: Managing Coagulopathy and the Bleeding Diathesis. Transplantation Proceedings 2009;41:1256-9. [DOI: 10.1016/j.transproceed.2009.03.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
68 Schwartz JJ, Hatch JM, Book Z, Lonardo N, Hutson WR, Sorensen JB. Use of argatroban during multi-organ procurement: pharmacokinetics and sequelae in recipient of transplanted liver. Clin Transplant 2009;23:705-9. [PMID: 19637991 DOI: 10.1111/j.1399-0012.2009.01042.x] [Reference Citation Analysis]
69 Stockschlaeder M, Schneppenheim R, Budde U. Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis. Blood Coagul Fibrinolysis. 2014;25:206-216. [PMID: 24448155 DOI: 10.1097/mbc.0000000000000065] [Cited by in Crossref: 102] [Cited by in F6Publishing: 40] [Article Influence: 17.0] [Reference Citation Analysis]
70 Nedel WL, Rodrigues Filho EM, Pasqualotto AC. Thrombin activatable fibrinolysis inhibitor as a bleeding predictor in liver transplantation: a pilot observational study. Rev Bras Ter Intensiva 2016;28:161-6. [PMID: 27410412 DOI: 10.5935/0103-507X.20160031] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Mahmoud NI, Messiha BA, Salehc IG, Abo-saif AA, Abdel-bakky MS. Interruption of platelets and thrombin function as a new approach against liver fibrosis induced experimentally in rats. Life Sciences 2019;231:116522. [DOI: 10.1016/j.lfs.2019.05.078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
72 Poordad F. Review article: thrombocytopenia in chronic liver disease. Aliment Pharmacol Ther 2007;26 Suppl 1:5-11. [PMID: 17958514 DOI: 10.1111/j.1365-2036.2007.03510.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
73 Hum J, Amador D, Shatzel JJ, Naugler WE, Ahn J, Zaman A, Chang M, Jou JH. Thromboelastography Better Reflects Hemostatic Abnormalities in Cirrhotics Compared With the International Normalized Ratio. J Clin Gastroenterol 2020;54:741-6. [PMID: 31764489 DOI: 10.1097/MCG.0000000000001285] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
74 Saray A, Mesihovic R, Vanis N, Amila M. Protein C Deficiency in Chronic Hepatitis C: Correlation With Histological Extent of Liver Fibrosis. Clin Appl Thromb Hemost 2017;23:72-7. [DOI: 10.1177/1076029615587356] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
75 Al-Dorzi HM, Tamim HM, Aldawood AS, Arabi YM. Venous thromboembolism in critically ill cirrhotic patients: practices of prophylaxis and incidence. Thrombosis 2013;2013:807526. [PMID: 24386564 DOI: 10.1155/2013/807526] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
76 Chandrasegaram MD, Eslick GD, Lee W, Brooke-Smith ME, Padbury R, Worthley CS, Chen JW, Windsor JA. Anticoagulation policy after venous resection with a pancreatectomy: a systematic review. HPB (Oxford) 2014;16:691-8. [PMID: 24344986 DOI: 10.1111/hpb.12205] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
77 Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood. 2010;116:878-885. [PMID: 20400681 DOI: 10.1182/blood-2010-02-261891] [Cited by in Crossref: 357] [Cited by in F6Publishing: 294] [Article Influence: 32.5] [Reference Citation Analysis]
78 Park J, Joo MA, Choi HJ, Hong SH, Park CS, Choi JH, Chae MS. Predictive utility of fibrinogen in acute kidney injury in living donor liver transplantation: A propensity score-matching analysis. PLoS One 2021;16:e0252715. [PMID: 34086798 DOI: 10.1371/journal.pone.0252715] [Reference Citation Analysis]
79 Moguilevitch M, Broderick C. Intracardiac Thrombosis during Adult Liver Transplantation. Case Rep Transplant. 2013;2013:618352. [PMID: 23984168 DOI: 10.1155/2013/618352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
80 Hirschfield GM, Kumagi T, Heathcote EJ. Preventative hepatology: minimising symptoms and optimising care. Liver Int 2008;28:922-34. [PMID: 18783540 DOI: 10.1111/j.1478-3231.2008.01816.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
81 Matsuzawa S, Reed JC. Yeast and mammalian two-hybrid systems for studying protein-protein interactions. Methods Mol Biol. 2007;383:215-225. [PMID: 18217688 DOI: 10.1097/MBC.0b013e3282f9b17f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
82 Flower O, Phillips LE, Cameron P, Gunn K, Dunkley S, Watts A, Rajbhandari D. Recombinant activated factor VII in liver patients: a retrospective cohort study from Australia and New Zealand. Blood Coagul Fibrinolysis 2010;21:207-15. [PMID: 20182351 DOI: 10.1097/MBC.0b013e3283333589] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
83 Kim J, Jung K, Lee S, Chu K, Roh J. Central nervous system complications after liver transplantation. Journal of Clinical Neuroscience 2015;22:1355-9. [DOI: 10.1016/j.jocn.2015.03.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]